CD274 and neoplasm: To exclude that these observations resulted from an impact of tumor size on efficacy of anti-PD-L1 therapy, we adjusted cell numbers of Cgas overexpression cells and chose tumors with similar sizes to Ctrl tumors for anti-PD-L1 therapy.